Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China
BMC Infectious Diseases·
- DOI
- 10.1186/s12879-024-10198-2
- PMID
- 39578769
- PMCID
- PMC11583410
- OpenAlex
- W4404613445
- Study type
- Journal article
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The study highlights diagnostic challenges of Chlamydia psittaci pneumonia given its atypical presentation and the limited sensitivity of routine testing, and suggests mNGS and doxycycline as relevant tools for clinical recognition and management.
Structured evidence summary
Research question
The study retrospectively compared clinical, laboratory, imaging, treatment, and prognostic features between severe and non-severe Chlamydia psittaci pneumonia to inform earlier recognition and management.
Study design
Multicenter retrospective case series across 12 Chinese provinces, classifying 61 pneumonia cases into severe (n=23) and non-severe (n=38) groups for comparison of imaging, laboratory, treatment, and prognostic variables.
Population and setting
61 patients with Chlamydia psittaci pneumonia drawn from 12 provinces in China, stratified as 23 severe and 38 non-severe cases.
Main findings
Severe and non-severe groups did not differ in age, sex, exposure history, smoking, or comorbidities. Fever (median 39.7°C) was the most prominent symptom. White blood cell and neutrophil counts often remained near normal, while CRP, procalcitonin, and arterial oxygen pressure reductions were notable; some patients showed hepatic or renal dysfunction without between-group difference. Doxycycline was the preferred therapy. Imaging typically showed consolidation with air bronchogram, occasionally ground-glass changes, solid masses, or pleural effusion, with mNGS contributing to diagnosis. The authors report differences in laboratory and imaging between severity groups that may aid early identification of severe cases, and note that timely treatment was associated with good prognosis and radiographic resolution.
Public-health relevance
The study highlights diagnostic challenges of Chlamydia psittaci pneumonia given its atypical presentation and the limited sensitivity of routine testing, and suggests mNGS and doxycycline as relevant tools for clinical recognition and management.
Important limitations
The abstract does not state explicit study limitations. This summary is limited to the supplied single-article abstract and bibliographic metadata and requires the original full text for decision-grade interpretation.
GIDS interpretation
From a discoverability standpoint, the paper consolidates multicenter Chinese experience with Chlamydia psittaci pneumonia diagnosis and treatment and may help clinicians locate characteristic imaging and laboratory patterns; it does not, on its own, constitute confirmation of any active surveillance signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 11 auditable classifier relationships to diseases, places, topics, and study design.